{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:07:43Z","timestamp":1768014463070,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jdcr.2020.09.020","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T09:21:31Z","timestamp":1602148891000},"page":"1264-1267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment"],"prefix":"10.1016","volume":"6","author":[{"given":"Taylor C.","family":"Duke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjit","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Torres-Cabala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodabe N.","family":"Amaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swaminathan P.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Heberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdcr.2020.09.020_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the International peripheral T-Cell lymphoma project","volume":"31","author":"Federico","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.09.020_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the non-Hodgkins lymphoma classification project","volume":"13","author":"R\u00fcdiger","year":"2002","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jdcr.2020.09.020_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000370302","article-title":"Angioimmunoblastic T-cell lymphoma: a diagnostic challenge","volume":"6","author":"Ocampo-Garza","year":"2014","journal-title":"Case Rep Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2020.09.020_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaad.2010.05.030","article-title":"Evaluation of cutaneous angioimmunoblastic T-cell lymphoma","volume":"65","author":"Balaraman","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2020.09.020_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DAD.0000000000000144","article-title":"Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics","volume":"37","author":"Botros","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.09.020_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s002960000056","article-title":"Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis","volume":"20","author":"Pay","year":"2000","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.jdcr.2020.09.020_bib7","first-page":"44","article-title":"Angioimmunoblastic T-cell lymphoma (AIL-TCL) following macrolide administration","volume":"59","author":"Sasaki","year":"2000","journal-title":"Hawaii Med J"},{"issue":"1","key":"10.1016\/j.jdcr.2020.09.020_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/030089160308900120","article-title":"Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration","volume":"89","author":"Batinac","year":"2003","journal-title":"Tumori"},{"issue":"1","key":"10.1016\/j.jdcr.2020.09.020_bib9","doi-asserted-by":"crossref","first-page":"e000104","DOI":"10.1136\/jitc-2019-000104","article-title":"T-cell lymphoma secondary to checkpoint inhibitor therapy","volume":"8","author":"Anand","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.jdcr.2020.09.020_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/CMR.0000000000000371","article-title":"Development of a biclonal cutaneous T-cell lymphoproliferative process during treatment with immune checkpoint inhibitors for metastatic melanoma","volume":"27","author":"Davick","year":"2017","journal-title":"Melanoma Res"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620306986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620306986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:48Z","timestamp":1762474968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620306986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2352512620306986"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.09.020","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}